Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chabner

Showing results (111-120 of 456) with videos related to

Pageof 46
Sort By:
The New England Journal of Medicine|February 20, 1992
Progress against rare and not-so-rare cancersB A Chabner, M A Friedman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
On receptor inhibitors and chemotherapyP D Ryan, B A Chabner
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Plant alkaloidsB A Chabner, S B Horwitz
Clinical Chemistry|August 1, 1996
Concepts in use of high-dose methotrexate therapyS P Treon, B A Chabner
Cancer Treatment Reports|May 1, 1977
Allergic reaction to cyclophosphamide in a mechlorethamine-sensitive patientW E Ross, B A Chabner
Biochimica Et Biophysica Acta|July 13, 1972
Activation and inhibition of carboxypeptidase G 1 by divalent cationsB A Chabner, J R Bertino
Nature Reviews. Cancer|January 5, 2005
Timeline: Chemotherapy and the war on cancerBruce A Chabner, Thomas G Roberts
Lancet (London, England)|August 31, 1991
Medical oncology in the 1990sB A Chabner, M L Rothenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Clarification regarding "phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties" and the accompanying commentary, "phase II cancer trials: out of control?"Bruce A Chabner, Mark J Ratain
Journal of the National Cancer Institute|May 18, 1988
Meeting highlights: William Guy Forbeck Foundation think tank on "multidrug resistance in cancer chemotherapy"B A Chabner, M M Gottesman
Pageof 46

Showing results (111-120 of 456) with videos related to

Sort By:
Pageof 46
The New England Journal of Medicine|February 20, 1992
Progress against rare and not-so-rare cancersB A Chabner, M A Friedman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
On receptor inhibitors and chemotherapyP D Ryan, B A Chabner
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
Plant alkaloidsB A Chabner, S B Horwitz
Clinical Chemistry|August 1, 1996
Concepts in use of high-dose methotrexate therapyS P Treon, B A Chabner
Cancer Treatment Reports|May 1, 1977
Allergic reaction to cyclophosphamide in a mechlorethamine-sensitive patientW E Ross, B A Chabner
Biochimica Et Biophysica Acta|July 13, 1972
Activation and inhibition of carboxypeptidase G 1 by divalent cationsB A Chabner, J R Bertino
Nature Reviews. Cancer|January 5, 2005
Timeline: Chemotherapy and the war on cancerBruce A Chabner, Thomas G Roberts
Lancet (London, England)|August 31, 1991
Medical oncology in the 1990sB A Chabner, M L Rothenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Clarification regarding "phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties" and the accompanying commentary, "phase II cancer trials: out of control?"Bruce A Chabner, Mark J Ratain
Journal of the National Cancer Institute|May 18, 1988
Meeting highlights: William Guy Forbeck Foundation think tank on "multidrug resistance in cancer chemotherapy"B A Chabner, M M Gottesman
Pageof 46